Hypothesis & Theory
Published on 22 Nov 2022
Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
Pathology and Oncology Research
doi 10.3389/pore.2022.1610687
Type at least 3 characters
2,905 articles
Articles
Original Research
Published on 22 Nov 2022
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610697
Hypothesis & Theory
Published on 07 Nov 2022
A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610643
Original Research
Published on 07 Nov 2022
KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
Pathology and Oncology Research
doi 10.3389/pore.2022.1610754
Hypothesis & Theory
Published on 03 Nov 2022
Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610538
Original Research
Published on 01 Nov 2022
Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients
Pathology and Oncology Research
doi 10.3389/pore.2022.1610396
Case Report
Published on 21 Oct 2022
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610638
Original Research
Published on 18 Oct 2022
Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610699
Original Research
Published on 18 Oct 2022
Improved Accuracy of Lymph Node Staging and Long-Term Survival Benefit in Colorectal Cancer With Ex Vivo Arterial Methylene Blue Infiltration
Pathology and Oncology Research
doi 10.3389/pore.2022.1610742
Hypothesis & Theory
Published on 13 Oct 2022
Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610610
Review
Published on 11 Oct 2022
Pulmonary Large Cell Neuroendocrine Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610730
Correction
Published on 06 Oct 2022
Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610658
Original Research
Published on 06 Oct 2022
Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
Pathology and Oncology Research
doi 10.3389/pore.2022.1610537
Hypothesis & Theory
Published on 05 Oct 2022
Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610670
Original Research
Published on 05 Oct 2022
EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
Pathology and Oncology Research
doi 10.3389/pore.2022.1610607
Original Research
Published on 03 Oct 2022
Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
Pathology and Oncology Research
doi 10.3389/pore.2022.1610645